EE427 Annual Cost Savings From the Use of Empagliflozin Over DPP4I in Select Asia-Pacific Countries – Estimates Based on the Emprise East Asia Study

Autor:	L Varghese, G Alcantara, P Germanos, Y Sumettavanich, A Das, J Gordon
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S139
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.673
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2044371a519f9fc4f58e431e02948cea https://doi.org/10.1016/j.jval.2022.09.673 Zobrazit plný text záznamu Full Text from ScienceDirect